insitro Tech Stack

AI platform for causal drug discovery across neuroscience and metabolic diseases

Biotechnology Research South San Francisco, California 201–500 employees Founded 2018 Privately Held

insitro combines multi-modal human and cellular data with causal AI models to accelerate therapeutic discovery. The tech stack—Python, PyTorch, TensorFlow, RDKit, Nextflow, and cloud infrastructure across AWS/GCP/Azure—reflects a data-intensive, computationally heavy research operation. Hiring velocity is accelerating with leadership-level openings (director, VP, C-suite) in research and healthcare, paired with active projects spanning phase 1 trial design, bioassay development, and agentic AI tooling, signaling a transition from discovery-stage work into clinical execution and operational scaling.

Tech Stack 20 technologies

Core StackPython PyTorch TensorFlow PostgreSQL MySQL AWS Pandas Apache Airflow Apache Spark Tecan Benchling CMMS RDKit GCP Azure Polars Nextflow Snakemake Ray Dask

What insitro Is Building

◆Challenges

Drug development acceleration
Bottlenecks in drug discovery pipeline
Lack of disease-relevant cell models
Inefficient high-throughput screening
Disruptive team dynamics
Ineffective organizational setups
Clinical trial efficiency
Advancing drug candidates into clinic
Optimizing high-throughput imaging experiments
Identifying novel disease phenotypes

▲Active Projects

Phase 1 trial design and execution
Cellml platform
Develop monitoring for evolving algorithms
Bioassay development
Clinical program plans
Clinical data package generation
Ai-forward ppm organization
Agentic ai project management tools
Optical screening platform
Build robust image analysis workflows

Hiring Activity

Accelerating15 roles · 7 in 30d

Department

Research

Healthcare

Ops

Data

Engineering

Seniority

Senior

Director

Mid

C-Level

Notable leadership hires: Project Team Lead

Company intelligence

Find more companies like insitro by tech stack, pain points and active projects

Get started free

About insitro

insitro is an AI therapeutics company developing computational models of human biology to identify causal drivers of disease and design optimal medicines. Founded in 2018 and headquartered in South San Francisco, the company operates across 201–500 employees with a research-forward organizational structure supported by healthcare operations and data infrastructure. The platform integrates human genetic data with cellular-scale experiments to power drug development pipelines in neuroscience and metabolic disease, with active programs advancing candidates toward clinical trials.

HeadquartersSouth San Francisco, California

Company Size201–500 employees

Founded2018

Hiring MarketsUnited States

Frequently Asked Questions

What technology does insitro use for drug discovery?

insitro's stack includes Python, PyTorch, TensorFlow, RDKit (for chemistry), Nextflow (workflow automation), PostgreSQL/MySQL for data, and AWS/GCP/Azure cloud infrastructure—built for high-throughput biological data processing and causal AI modeling.

What projects is insitro working on?

Active projects include phase 1 trial design and execution, bioassay development, optical screening platform buildout, clinical data package generation, image analysis workflows, and agentic AI tools for project management.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Calico Life Sciences

Biotechnology Research

Ultima Genomics

Biotechnology Research

Generate:Biomedicines

Biotechnology Research

ProBioGen AG

Biotechnology Research

How this profile is built

insitro's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.